內 容
|
「國家新創獎」作為國內生醫大健康與跨域創新領域最高指標獎項，其中「學研新創獎」係學研團隊展現創新突破之關鍵場域。
一、本年度開放七大類別之創新領域申請：
(1)智慧醫療與健康科技
(2)生技製藥與精準醫療
(3)創新醫材與鳥診斷技衛
(4)農業與食品生技
(5)特化材料與應用生技
(6)環境科技與能源應用
(7)創新防疫科技
二、「國家新創獎」由90位醫界權威、科研領袖、政府首長、產業科技與投資評估專家共同遴選推薦、指引產品開發與市場路徑，歷屆獲獎團隊不僅為產業尋求研發、授權與投資標的之首站，歷年打造之亞太最大規模Demo Day~更為新創團隊竭力爭取、吸引國際目光之最高榮耀殿堂！匯聚來自醫療與學術機構之豐沛研發量能，「國家新創獎」將提供參賽優秀隊伍技術商化策略指引、持續籌辦「Inno Zone」國際Roadshow特展，並助力鏈結資本創投、臨床開發、法律智財、財會稅務、國際市場等關鍵資源，激勵與加速推進創新創業、驅動產業新星！
三、本年度申請時程自即日起至115年7月31日截止。申請費用為每一參賽案伍萬伍仟元整，相關申請辦法及審查關鍵指標等資訊，敬請參閱官網。
有關參賽申請諮詢請洽02-26557888#616林雨慷專案副理；
若為參賽備審諮詢請洽#634陳柏翔博士。
The National Innovation Award is the highest-level award in the fields of biomedicine, healthcare, and interdisciplinary innovation in Taiwan. The "Academia-Research Innovation Award" is a key platform for academic and research teams to demonstrate innovative breakthroughs.
I. This year, applications are open in seven categories of innovation:
(1) Smart Healthcare and Health Technology
(2) Biopharmaceuticals and Precision Medicine
(3) Innovative Medical Devices and Bird Diagnostic Technology
(4) Agricultural and Food Biotechnology
(5) Specialized Materials and Applied Biotechnology
(6) Environmental Technology and Energy Applications
(7) Innovative Epidemic Prevention Technology
II. The National Innovation Award is jointly selected and recommended by 90 medical authorities, research leaders, government officials, and industry technology and investment evaluation experts. These experts guide product development and market pathways. Winning teams have become the primary destination for industries seeking R&D, licensing, and investment targets. The annual Asia-Pacific is largest Demo Day is the highest honor that startups strive to achieve, attracting international attention! Bringing together abundant R&D resources from medical and academic institutions, the "National Innovation Award" will provide outstanding participating teams with guidance on technology commercialization strategies, continue to organize the "Inno Zone" international roadshow, and help connect key resources such as venture capital, clinical development, legal and intellectual property, accounting and taxation, and international markets, encouraging and accelerating innovation and entrepreneurship and driving the rise of new industry stars!
III. The application period for this year is from now until July 31, 2026. The application fee is NT$55,000 per entry. For information on application methods and key review criteria, please visit the official website.For inquiries about the application process, please contact Project Manager Lin Yu-Kang at 02-26557888#616; for inquiries about the application preparation process, please contact Dr. Chen Bo-Xiang#634. |
|